SCHEMBL7901737

SCHEMBL7901737

CC(=N)N(CCCC[C@H](N)C(=O)O)OC(=O)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 4/20 0.41
NOS3 P29474 3/20 0.41
NOS2 P35228 3/20 0.41
POLB P06746 1/20 0.40
KMT2A Q03164 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
SLC7A5 Q01650 3/20 0.39
SLC1A5 Q15758 3/20 0.39
ALPI P09923 1/20 0.37
PKM P14618 1/20 0.37
PTGS1 P23219 1/20 0.37
XIAP P98170 1/20 0.37
DPP7 Q9UHL4 1/20 0.36
KIF11 P52732 3/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
TSHR P16473 1/20 0.36
GSR P00390 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7909596 0.84 MAPT (0.40) NOS1NOS3NOS2POLBKMT2A
SCHEMBL7909588 0.84 MAPT (0.40) NOS1NOS3NOS2POLBKMT2A
SCHEMBL7911875 0.82 NOS3 (0.43) NOS1NOS3NOS2POLBKMT2A
SCHEMBL7220222 0.82 NOS2 (0.49) NOS1NOS3NOS2KMT2ACYP1A2
SCHEMBL7911979 0.81 L3MBTL1 (0.44) NOS1NOS3NOS2POLBKMT2A
Hydrochloric Acid SCHEMBL8201921 0.80 L3MBTL1 (0.43) NOS1NOS3NOS2POLBKMT2A
SCHEMBL7912026 0.79 NOS2 (0.47) NOS1NOS3NOS2KMT2ACYP1A2
SCHEMBL8821865 0.77 POLB (0.40) NOS1NOS3NOS2POLBKMT2A
SCHEMBL7908808 0.77 NOS2 (0.44) NOS1NOS3NOS2KMT2ACYP1A2
SCHEMBL7911865 0.77 NOS2 (0.44) NOS1NOS3NOS2KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207708-B1 FOR THERAPY AND PROPHYLAXIS OF AUTOIMMUNE AND/OR INFLAMMATORY CONDITIONS AFFECTING THE JOINTS SUCH AS ARTHRITIS, AND INFLAMMATORY BOWEL DISEASE, CARDIVASCULAR ISCHEMIA, DIABETES, CONGESTIVE HEART FAILURE, MYOCARDITIS, ATHEROSCLEROSIS, G. D. SEARLE & COMPANY 2001-03-27 US claimed
EP-0885188-B1 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS SEARLE & CO (US) 2000-09-27 EP claimed
EP-0885188-A1 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1998-12-23 EP claimed
WO-1997032844-A9 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS 1997-12-24 WO claimed
WO-1997032844-A1 HYDROXYAMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1997-09-12 WO claimed